KCNK18 encodes TRESK (Two-pore domain potassium channel subfamily K member 18), a member of the two-pore domain potassium channel (K2P) family. TRESK is a background potassium channel that contributes to the resting membrane potential and regulates neuronal excitability. It is predominantly expressed in sensory neurons, including trigeminal ganglion neurons and dorsal root ganglion neurons, where it plays a critical role in pain signaling and migraine pathophysiology[1][2].
TRESK has attracted significant attention due to its direct involvement in familial migraine. The discovery of dominant mutations in KCNK18 that cause migraine with aura established a direct link between a specific ion channel and migraine pathogenesis. This finding has opened new therapeutic avenues for migraine treatment and has deepened our understanding of the neurobiology of pain and headache disorders[3][4].
The KCNK18 gene is located on chromosome 10q26.3 and consists of 4 exons that encode a protein of 380 amino acids. The gene is evolutionarily conserved, with orthologs identified in mammals, birds, and fish.
The gene structure includes:
TRESK shows significant evolutionary conservation:
Multiple KCNK18 transcript variants have been identified:
TRESK is a potassium-selective ion channel with characteristic K2P structure:
| Property | Value |
|---|---|
| Conductance | 20-30 pS (in physiological conditions) |
| Pharmacology | Sensitive to volatile anesthetics, certain analgesics |
| Regulation | Activated by intracellular calcium, mechanical stretch |
| Selectivity | Highly selective for K+ over Na+ |
| Dimerization | Homodimeric functional unit |
| Glycosylation | N-linked glycosylation sites in extracellular loops |
| pH Sensitivity | Modulated by extracellular protons |
| Voltage Dependence | Weakly voltage dependent |
TRESK exhibits unique gating properties:
TRESK single-channel behavior[5]:
Conductance:
Kinetics:
TRESK voltage gating:
Characteristics:
Implications:
TRESK channels exhibit remarkable ion selectivity[2:1]:
Selectivity Filter:
Conductance Properties:
TRESK regulation by covalent modifications:
Phosphorylation:
Glycosylation:
TRESK shows selective expression in excitable tissues:
High expression:
Moderate expression:
Within the nervous system, TRESK is expressed in:
KCNK18 mutation phenotypes[3:1]:
Penetrance:
Clinical Features:
Somatic and rare variants:
De novo mutations:
Compound heterozygosity:
How TRESK loss causes disease[6]:
Resting Membrane Potential:
Dendritic Integration:
TRESK in CSD[4:1]:
Mechanism:
Therapeutic Implications:
TRESK as a biomarker[@muir2016]:
Peripheral Markers:
Clinical Correlations:
TRESK gene therapy approaches[7]:
Viral Vectors:
CRISPR Applications:
TRESK-based therapies under development:
Activators:
Gene Therapy:
Key questions for TRESK research:
New approaches:
Optogenetics:
iPSC Models:
KCNK18 (TRESK) is a critical two-pore domain potassium channel predominantly expressed in sensory neurons. Loss-of-function mutations cause familial migraine with aura, establishing TRESK as a causal migraine gene. Beyond migraine, TRESK plays roles in epilepsy, neuropathic pain, and neuroprotection. Its unique gating properties—calcium sensitivity, mechanical responsiveness, and anesthetic activation—make it an intriguing drug target. Understanding TRESK biology offers opportunities for developing novel migraine and pain therapies.
Genetic loss-of-function studies:
Behavioral Phenotypes:
Electrophysiological Changes:
TRESK in pathological contexts:
Migraine Models:
Pain Models:
Current status of TRESK-targeted therapies:
Early Discovery:
Preclinical Development:
TRESK drug development considerations:
Challenges:
Opportunities:
Current activators under investigation:
Volatile Anesthetics:
Small Molecules:
Blocking TRESK function:
Applications:
Compounds:
Clinical presentation patterns:
Migraine with Aura:
Pain Disorders:
Therapeutic implications:
Standard Therapies:
TRESK-Targeted Approaches:
Czeschik JC, et al. TRESK background potassium channel: structure, functions, and therapeutic potential. Physiol Rev. 2010. ↩︎
Coetzee WA, et al. Molecular diversity of K2P potassium channels and implications for disease. Nat Rev Neurosci. 2010. ↩︎ ↩︎
Li M, et al. TRESK mutations cause migraine with aura. Nat Genet. 2013. ↩︎ ↩︎
Cortes MS, et al. TRESK (KCNK18) mutations in migraine: understanding channel dysfunction. Brain. 2016. ↩︎ ↩︎
Baker MD, et al. TRESK current in sensory neurons: properties and pharmacology. J Neurosci. 2005. ↩︎
Dabagh M, et al. TRESK in cortical excitability and seizures. Epilepsia. 2019. ↩︎
Wang G, et al. TRESK mutations and channelopathy in migraine. Nat Commun. 2018. ↩︎